Effects of Clioquinol Analogues on the Hypoxia-Inducible Factor Pathway and Intracelullar Mobilization of Metal Ions

Authors
Kim, So YeonLee, Myong JinKim, Jeong WonNa, Yu-RanLee, Ho-YoulCho, HyunjuLee, Keun ByeolLee, You MieLee, CheoljuPark, HyunsungYang, Eun Gyeong
Issue Date
2012-12
Publisher
PHARMACEUTICAL SOC JAPAN
Citation
BIOLOGICAL & PHARMACEUTICAL BULLETIN, v.35, no.12, pp.2160 - 2169
Abstract
We previously found that clioquinol (CQ) increases functional hypoxia-inducible factor-1 alpha (HIF-1 alpha) with enhanced transcription of its target genes. Here we report that compounds derived from 8-hydroxyquinoline including CQ, broxyquinoline (BQ), iodoquinol (IQ) and chloroacetoxyquinoline (CAQ) promote neovascularization effectively based on chick chorioallantoic membrane assays. The CQ analogues induce stabilization of H IF-1 alpha as well as enhance HIF-1-mediated vascular endothelial growth factor transcription. These analogues also exert inhibitory effects on the activity of prolyl and asparaginyl hydroxylations of H IF-1 alpha in vitro. Despite metal ion-dependent restoration of the inhibited HIF-1 alpha hydroxylase activity, the cellular HIF-1 alpha-inducing effects of the CQ analogues are reversed to varying degrees by Zn2+ and Fe2+. While CQ and BQ are completely reversed by Zn2+, co-administration of Zn2+ and IQ has only a partial reversing effect. On the other hand, CAQ-mediated stabilization of HIF-1 alpha is reversed by Fe2+ but not by Zn2+. These phenomena are found to coincide with elevation of the intracellular Zn2+ and Fe2+ levels by the CQ analogues, suggesting that metal ion effects on H IF-la in cells likely reflect the differential transporting capability of the analogues.
Keywords
PROLYL HYDROXYLASE INHIBITORS; UBIQUITIN-PROTEASOME PATHWAY; ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC TARGET; ALZHEIMERS-DISEASE; CANCER-THERAPY; FACTOR 1-ALPHA; FACTOR-I; ANGIOGENESIS; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; PROLYL HYDROXYLASE INHIBITORS; UBIQUITIN-PROTEASOME PATHWAY; ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC TARGET; ALZHEIMERS-DISEASE; CANCER-THERAPY; FACTOR 1-ALPHA; FACTOR-I; ANGIOGENESIS; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; 8-hydroxyquinoline derivative; hypoxia-inducible factor-1 alpha; zinc ion; prolyl hydroxylase domain 2; factor-inhibiting hypoxia-inducible factor-1; angiogenesis
ISSN
0918-6158
URI
https://pubs.kist.re.kr/handle/201004/128615
DOI
10.1248/bpb.b12-00507
Appears in Collections:
KIST Article > 2012
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE